Psychoactive Substance Abuse Screening in Assisted Living Communities
GIA® integrates into the daily rhythm of assisted living — a video check-in during morning rounds or a phone call during quiet hours. Residents experience a conversation, not a clinical test.
Why Psychoactive Substance Abuse goes undetected in assisted living communities
Personal care aides and medication technicians provide most direct care. Licensed nursing presence is limited. Clinical screening capacity is minimal. Psychoactive Substance Abuse symptoms are often subtle, progressive, and easily attributed to other factors in this care environment.
Residents often present with subtle cognitive changes that staff are not trained to detect
No MDS requirement means screening often does not happen until a crisis
Families expect proactive monitoring but staffing rarely supports it
Missed early detection leads to avoidable transfers to skilled nursing or hospitals
How does GIA® screen for Psychoactive Substance Abuse in assisted living communities?
GIA® meets the patient by video, voice, or landline — wherever they are in the assisted living communitie environment. The screening conversation takes under five minutes and feels like a natural check-in, not a clinical assessment.
During the conversation, GIA® analyzes over 2,500 speech biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load indicators — alongside 436 visual data points from facial micro-expressions and body movement during video sessions.
Results are delivered to the clinician in 60 seconds. Four data types write back to the EHR automatically: structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video. The clinician reviews and submits — the human is always in the loop.
What compliance requirements does this address?
State licensing requirements vary but increasingly mandate cognitive and behavioral health screening. Early detection prevents costly level-of-care transitions.
GIA® produces survey-ready documentation automatically — structured screening results, medical notes, full transcripts, and patient video — all written back to the EHR in real time. When a surveyor asks how you screen for psychoactive substance abuse, the answer is in the patient record: timestamped, structured, and reviewable.
Psychoactive Substance Abuse screening in assisted living communities
How is Psychoactive Substance Abuse screened in assisted living communities?
GIA® screens for Psychoactive Substance Abuse through a single conversational interaction lasting under 5 minutes. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. GIA® integrates into the daily rhythm of assisted living — a video check-in during morning rounds or a phone call during quiet hours. Residents experience a conversation, not a clinical test. Results are delivered to the clinician in 60 seconds.
Does Psychoactive Substance Abuse screening require additional staff?
No. GIA® conducts the screening conversation independently — zero additional clinical staff required during the interaction. Personal care aides and medication technicians provide most direct care. Licensed nursing presence is limited. Clinical screening capacity is minimal. The clinician reviews the results in under 2 minutes.
What is the accuracy of Psychoactive Substance Abuse screening?
Psychoactive Substance Abuse screening accuracy: 75.1% accuracy. The platform is 510(k) registered and trained on 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events.
Psychoactive Substance Abuse screening in other care settings
Other conditions screened in assisted living communities
See GIA® screen for Psychoactive Substance Abuse live
Under 5 minutes. 60-second results. Zero staff time.